Skip to main content
. 2017 Jun 20;8:362. doi: 10.3389/fphar.2017.00362

Table 1.

Combined use of GABA and sitagliptin elevates plasma insulin and GLP-1 levels, while decreases plasma glucagon levels.

Baseline Water GABA Sita GABA+Sita F-values P-values
Insulin (ng/ml) 0.67 ± 0.08 0.30 ± 0.02 0.52 ± 0.14ˆ* 0.44 ± 0.10ˆ*# 0.77 ± 0.22ˆ** 8.43 <0.001
Glucagon (pg/ml) 175.0 ± 21.9 383.8 ± 37.5 212.7 ± 14.5ˆ** 227.8 ± 14.8ˆ**# 199.9 ± 17.1ˆ** 54.89 <0.0001
GLP-1 (pmol/L) 5.26 ± 1.31 2.13 ± 0.43 2.94 ± 0.76 5.10 ± 0.45ˆ**## 6.93 ± 0.29ˆ*** 19.28 <0.001

Data are Mean ± SD. P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. diabetic control group (Water group); #P < 0.05, ##P < 0.01 vs. GABA+sitagliptin treated group.